ArriVent BioPharma, Inc. 10-Q

Accession 0001104659-26-058650

Filing information

CIK: 0001868279
Report date: 2026-03-31
Filing date: 2026-05-11
Form: 10-Q
Primary document: avbp-20260331x10q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.